In 1962, John F. Kennedy declared that the United States would go to the moon and in 1969, we did. Now President Obama is calling for the same level of national focus and dedication to win the war against cancer. He announced a new “moonshot” during his last State of the Union Address - a moonshot to cure cancer.Read More
Science Market Update
On May 2nd, 2013, a very important addition to the WSU Pullman campus was dedicated. The Veterinary and Biomedical Research Building (VMRB) is now the seventh connected building in the WSU Research and Educational Complex. This new building will foster research relating specifically to biomedical questions revolving around human and animal health.
This development has been under construction since August 2010 and is the most newly added member to the Research and Educational Complex on the WSU Pullman campus. This $96 million dollar investment by WSU will focus on many health issues including:
- Heart health: How, by uncovering the biophysical mechanisms of cardiac muscle contraction, new discoveries into cardiac function and disease can be revealed.
- Emotional health: How understanding the basis of emotions of companion and production animals can improve the lives of people with affective disorders.
- Sleep and circadian rhythms: How rhythms, dysrhythms, and circadian biology affect animal biology and can improve and inhibit daily functions in animals and people.
- Neurological diseases: How neurodegenerative diseases, such as Parkinson’s disease, can be treated more effectively by discovering the underlying causes and subsequently creating treatments to repair the loss of functionality.
- Obesity and Diabetes: How obesity and diabetes can be prevented by studying and understanding the relationship between the consumption of food and how energy is consequently regulated into the body.
- Drug addiction: How the biological actions of commonly abused drugs can be used to reverse the destrctive nature of addiction and help prevent the relapses of drug users.
This research facility is operating east of the Martin Stadium entrance and south of the Beasley Coliseum parking lot. This building boasts 77,250 net square feet (128,000 gross square feet) of state-of-the-art space, highly suitable for biomedical research, health science teaching, and research programs. Also included in this structure is a vivarium (an indoor facility for safely housing animals and plants in their natural environments for humane scientific observation), which will allow for gene targeting of the animals and provide necessary quarantined space to guarantee uncontaminated research. These labs and offices were specifically designed with the Veterinary Medicine Department of Integrative Physiology and Neuroscience in mind.
On the subject of this exciting new development, WSU regent Scott Carson remarks, “This building is the beginning. It’s our opportunity to compete for those wonderful young people that will be coming here in the future - the researchers that will do wonderful work because of the collaborative environment that this represents.”
Washington State University’s College of Veterinary Medicine (CVM) is one of the top leaders in research benefiting to animal and human health and well being. In fact, solely during the 2006 fiscal year, the research faculty placed the CVM well into the top tier of all veterinary schools by working with over $12.5 million in competitively funded research.
Some of these specialized areas are:
*Food & water-borne diseases
*Cardiovascular medicine & physiology
*Immunology and infectious diseases
*Microbial genomics and proteomics
Tags: 2014, 2013, biomedical research, Washington, WSU Pullman, WA, Northwest, WA research, WSU, Washington State University, Washington Life Science, BioResearch Product Faire Event, buiding. new building, research science information, Biomedical Research Funding, Pullman
|(Courtesy of http://www.abc.net.au/)|
Every week we see commericals on television asking if we have Mesothelioma. By the number of commercials alone you would be right in thinking Mesothelioma is a serious problem. That's why it's particularly important that a major cancer research institution, the University of Hawaii Cancer Center, recently received a $600,000 grant from the Jimmy Valvano Foundation for Cancer Research. The grant was awarded to the research lab of pathologist Michele Carbone to study HGMB1: A Biomarker for Mineral Exposure and Detection of Malignant Mesothelioma. According to Dr. Carbone:
Funding makes laboratory research possible, which makes discovery possible, which leads to advancing knowledge and treatment options. But the primary job of a top scientist and lab director should not be to write grant proposals at the expense of time spent actually doing research. With that insight in mind, the University of California San Francisco put a system in place 5 years ago called the Resource Allocation Program (RAP). The function of the RAP is to streamline the intramural funding process so that faculty only have to fill out one application for many grants, and then only twice a year on set dates. A recent review of the program shows it to be a success, with a 66% increase in overall applications submitted and approximately a 20% increase in funding awarded in the past year alone.
Tags: CA, University of California San Francisco, biomedical research, 2012 Research Funding, Southwest, California, 2012, San Francisco, Funding, Biotechnology Vendor Showcase, UCSF, Biomedical Research Funding, Mission Bay Campus, UCSF Mission Bay
The first construction of an image by Nuclear Magnetic Resonance (NMRI) by Dr. Paul Lauterbur took place at the University at Stony Brook thirty years ago, and the Stony Brook Chemistry professor went on to win the 2003 Nobel Prize for his work. So it's fitting that another breakthrough in MRI technology is also taking place at the Long Island research university, this time by biomedical engineer Balaji Sitharaman, right, and his team, who have developed a potentially safer and more cost effective MRI contrast agent for improved disease diagnosis and detection. The agent is graphene-based rather than gadolinium-based, and the success of the advanced agent is documented in a recent PLoS ONE article.
Tags: biomedical sciences, biomedical research, Northeast, New York, Stony Brook University, venture development in life sciences, BioResearch Product Faire Event, Biomedical Research Funding, scientist solutions, life science products, science solution
Tags: Georgetown University, Washington DC, Northeast, Multiple Sclerosis, new science wet labs, 2012, Neuroscience, Geotwn, BioResearch Product Faire Event, Biomedical Research Funding, charitable giving
The University of Wisconsin at Madison is doing very well launching bioscience startups and attracting young entrepreneurs to set up shop near the sprawling campus on Lake Mendota. The University Research Park is so popular there's a huge Phase II addition several years in the planning and due to break ground any day. Funding for university spinoffs, like the NIH's Small Business Innovation Research (SBIR) grants, are helping to fuel Madison's bioscience economy too, as a team from the Dept. of Chemical and Biological Engineering just proved in securing $362,489 towards developing its novel advanced biomaterials for wound healing and surgical applications.
Tags: Midwest, Wisconsin, University of Wisconsin, University Research, university research park, University of Wisconsin Madison, BioResearch Product Faire Event, Funding, NIH, chemistry researchers, Biomedical Research Funding
The UC Davis Cancer Center was recently recognized as a "comprehensive" center by the National Cancer Institute (NCI). This is the most prestigious honor that a cancer center can receive and designates the renamed, UC Davis Comprehensive Cancer Center as one of the top cancer research institutions in the country.
Tags: biomedical sciences, University of California Davis, cancer research, Southwest, California, UC Davis Cancer Center, BioResearch Product Faire Event, BRPF, Biomedical Research Funding, Cancer Center, Sacramento Campus
An anonymous gift of $16 million in science research funding to the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania will fund the establishment of the Neuroscience of Behavior Initiative, which aims to strengthen Penn’s program in basic, translational, clinical and population research into the areas of addiction, depressive disorders and neurodegenerative disease. The gift is the single-largest donation for neuroscience research in the school’s history.